home / stock / scph / scph message board
Subject | By | Source | When |
---|---|---|---|
scPharmaceuticals Inc. discloses that it has two deposit | FooBarAndGrill | investorshub | 03/12/2023 3:15:26 AM |
$SCPH PR: | FooBarAndGrill | investorshub | 02/21/2023 3:57:27 PM |
Monday 20th is Go-To-Market. | FooBarAndGrill | investorshub | 02/17/2023 5:01:55 PM |
$SCPH provides business updates. | FooBarAndGrill | investorshub | 01/30/2023 4:44:21 PM |
Will $SCPH ever sell a single dose of | FooBarAndGrill | investorshub | 01/24/2023 2:29:10 AM |
The go-to-market for the Furoscix infusor/drug combo is | FooBarAndGrill | investorshub | 01/16/2023 3:43:01 PM |
Furoscix administered via the Furoscix Infusor. | FooBarAndGrill | investorshub | 12/28/2022 9:26:50 PM |
$SCPH Prescription Drug product FUROSCIX has been added | FooBarAndGrill | investorshub | 12/19/2022 4:48:00 PM |
$SCPH Prescription Drug product FUROSCIX has been added | FooBarAndGrill | investorshub | 12/08/2022 3:27:29 PM |
PDUFA! Approval! | FooBarAndGrill | investorshub | 10/10/2022 12:43:22 PM |
PDUFA! Approval! | FooBarAndGrill | investorshub | 10/10/2022 12:43:14 PM |
PDUFA After Market today? | FooBarAndGrill | investorshub | 10/07/2022 3:48:56 PM |
Whats up here today | akamaii | investorshub | 04/17/2019 12:34:09 PM |
News, Short Squeeze, Breakout and More Instantly...
scPharmaceuticals Inc. Company Name:
SCPH Stock Symbol:
NASDAQ Market:
scPharmaceuticals Inc. Website:
Generated 4Q 2023 net FUROSCIX ® revenue of $6.1 million, at the upper end of the range provided in January and representing sequential growth of 61% from $3.8 million in 3Q 2023 Generated full-year net FUROSCIX ® revenue of $13.6 million, at the upper end of the range...
SuRo Capital Corp. (SSSS) is expected to report for quarter end 2023-12-31 Enviva Inc. (EVA) is expected to report $-0.76 for Q4 2023 Jushi Holdings Inc. - Class B (Sub Voting) (JUSHF) is expected to report $-0.04 for Q4 2023 U Power Limited (UCAR) is expected to report for quarter en...
2024-03-08 00:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...